Antibody-drug conjugate (ADC) technology Educational session

Tumour-targeted immune-stimulating antibody conjugates (ISACs): A new class of immuno-oncology therapeutics (ID 38)

Lecture Time
15:15 - 15:30
Speakers
  • Shelley Ackerman (Redwood City, CA, United States of America)
Session Name
Antibody-drug conjugate (ADC) technology
Room
Channel 2
Date
Mon, 01.03.2021
Time
14:30 - 15:45
Authors
  • Shelley Ackerman (Redwood City, CA, United States of America)